MktsMarkets

Sonoma Pharmaceuticals, Inc.
NASDAQ: SNOAKey statistics
SNOA News
Stories mentioning SNOA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 5,561 | 4,349 | 5,604 | 4,015 | 3,754 | 3,564 | 3,579 | 3,391 |
| Cost of Goods Sold | 3,380 | 2,699 | 3,484 | 2,551 | 2,226 | 2,294 | 2,218 | 2,085 |
| Gross Profit | 2,181 | 1,650 | 2,120 | 1,464 | 1,528 | 1,270 | 1,361 | 1,306 |
| Operating Expenses | ||||||||
| Research & Development | 545.00 | 557.00 | 575.00 | 594.00 | 411.00 | 427.00 | 506.00 | 470.00 |
| Sales General & Admin | 1,987 | 1,771 | 1,882 | 1,965 | 1,773 | 1,874 | 1,705 | 2,009 |
| Total Operating Expenses | 2,532 | 2,328 | 2,457 | 2,559 | 2,184 | 2,301 | 2,211 | 2,479 |
| Operating Income (Loss) | (351.00) | (678.00) | (337.00) | (1,095) | (656.00) | (1,031) | (850.00) | (1,173) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (497.00) | (949.00) | (731.00) | (1,242) | (528.00) | (919.00) | (463.00) | (997.00) |
| Tax Provision | 84.00 | (130.00) | (197.00) | (1.00) | 248.00 | 9.00 | 147.00 | 146.00 |
| Net Income (Loss) | (581.00) | (819.00) | (534.00) | (1,241) | (776.00) | (928.00) | (610.00) | (1,143) |
| Earnings Per Share (Basic) | (0.35) | (0.48) | (0.32) | (0.76) | (0.63) | (0.63) | (0.59) | (1.34) |
| Earnings Per Share (Diluted) | (0.35) | (0.48) | (0.32) | (0.76) | (0.63) | (0.63) | (0.59) | (1.34) |
| Weighted Average Shares Outstanding (Basic) | 1,684 | 1,713 | 1,646 | 1,641 | 1,241 | 1,464 | 1,034 | 851.00 |
| Weighted Average Shares Outstanding (Diluted) | 1,684 | 1,713 | 1,646 | 1,641 | 1,241 | 1,464 | 1,034 | 851.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SNOA
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is a stock listed on the Nasdaq Stock Market under the ticker symbol SNOA. It last traded at $1.25 (Nov 11, 2026, 3:24 PM ET), up 9.7% on the day. That gives Sonoma Pharmaceuticals a market capitalisation of $5.5M.
Over the past 52 weeks SNOA has traded between $0.8500 and $3.95.
Revenue for the quarter ended Mar 31, 2026 was $5.6M; a net loss of $581.0K. Revenue was up 48.1% from $3.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $5.6M | -$581.0K | -10.4% |
| Dec 31, 2025 | $4.3M | -$819.0K | -18.8% |
| Sep 30, 2025 | $5.6M | -$534.0K | -9.5% |
| Jun 30, 2025 | $4.0M | -$1.2M | -30.9% |
From Sonoma Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…